Updated: January 27, 2026
M-M-R II Drug Interactions: What to Avoid and What to Tell Your Doctor
Author
Peter Daggett

Summarize with AI
- Why Does M-M-R II Have Drug Interactions at All?
- Category 1: Immunosuppressants — Contraindicated
- Category 2: Blood Products and Immune Globulins — Timing Issue
- Category 3: Other Live Vaccines — Timing Consideration
- Category 4: Tuberculin (TB) Skin Test — Timing Consideration
- What to Tell Your Doctor Before Getting M-M-R II
M-M-R II interacts with immunosuppressants, blood products, and other live vaccines. Here's what to tell your doctor before getting the MMR vaccine in 2026.
Because M-M-R II is a live-virus vaccine, it has a distinct interaction profile compared to inactivated vaccines. The most critical interactions involve medications that suppress the immune system — and the interactions can be serious, even life-threatening. Here is what every patient should know before receiving M-M-R II.
Why Does M-M-R II Have Drug Interactions at All?
M-M-R II works by introducing live but weakened viruses into the body. This requires your immune system to function normally in order to:
Contain the attenuated viruses so they do not cause disease
Generate an immune response (antibodies + memory cells) that provides protection
Any medication that significantly weakens the immune system can disrupt both of these processes — either causing the vaccine virus to cause actual disease (disseminated infection) or preventing an adequate immune response from forming (rendering the vaccine ineffective).
Category 1: Immunosuppressants — Contraindicated
M-M-R II is contraindicated in patients receiving immunosuppressive therapy. This includes:
High-dose corticosteroids: Prednisone, prednisolone, dexamethasone, and similar medications at immunosuppressive doses. Low doses used topically or for short courses are generally acceptable.
Biologic immunosuppressants: TNF inhibitors (adalimumab, etanercept, infliximab), IL inhibitors (belimumab, ixekizumab), JAK inhibitors, and similar agents used for rheumatoid arthritis, psoriasis, inflammatory bowel disease, and other autoimmune conditions
Chemotherapy agents: All chemotherapy regimens significantly suppress immune function. Live vaccines should be deferred until at least 3 months after chemotherapy is completed.
Transplant immunosuppression: Medications used to prevent organ rejection (tacrolimus, cyclosporine, mycophenolate) are contraindications to live vaccines.
CAR-T cell therapy: Live vaccines should not be given for at least 6 weeks before starting lymphodepleting chemotherapy, during treatment, or until immune recovery is confirmed.
Category 2: Blood Products and Immune Globulins — Timing Issue
Receiving blood products (blood transfusions, plasma) or immune globulins (IGIM, IGIV, or specific immune globulins like RSV-IGIV) near the time of vaccination can interfere with M-M-R II's effectiveness. Pre-formed antibodies in these products can neutralize the vaccine viruses before your immune system has a chance to respond.
The ACIP provides specific interval guidelines:
Do not give M-M-R II and blood products/immune globulins simultaneously
Wait at least 2 weeks after M-M-R II before giving blood products (otherwise the blood product may blunt the vaccine response)
Wait intervals after receiving blood products before giving M-M-R II range from 3-11 months depending on the specific product and dose — consult the ACIP table for specific intervals
Category 3: Other Live Vaccines — Timing Consideration
M-M-R II can be given concurrently with other live vaccines on the same day without concern. However, if two live vaccines are not given on the same day, they must be separated by at least 28 days (4 weeks). Giving two live vaccines within less than 28 days of each other can interfere with the immune response to both.
Relevant live vaccines that may be co-administered or need spacing:
Varicella (VARIVAX) — often given at the same visit as M-M-R II in children
Yellow fever vaccine — a common co-administration concern for travelers
Live oral typhoid vaccine — separate by 28 days if not given same day
Category 4: Tuberculin (TB) Skin Test — Timing Consideration
M-M-R II can temporarily suppress the reaction to a tuberculin (PPD) skin test, potentially causing a false-negative TB test result. To avoid this issue:
Administer the TB skin test before M-M-R II vaccination, simultaneously on the same day, OR
Wait at least 4-6 weeks after M-M-R II before performing a TB skin test
What to Tell Your Doctor Before Getting M-M-R II
Before receiving M-M-R II, tell your healthcare provider about:
All medications you take, including prescription drugs, over-the-counter medications, and supplements
Any immune-suppressing conditions (HIV/AIDS, cancer, organ transplant, autoimmune disease)
Recent blood transfusions or immune globulin treatments
Other vaccines you have received recently
Pregnancy or plans to become pregnant
Any history of allergic reactions to gelatin, neomycin, or prior vaccine components
Also read: M-M-R II Side Effects: What to Expect and When to Call Your Doctor
If you are ready to get vaccinated and need to find M-M-R II in stock near you, medfinder can help.
Frequently Asked Questions
No. Methotrexate is an immunosuppressive medication and is a contraindication to M-M-R II and other live vaccines. Receiving a live vaccine while on methotrexate can lead to disseminated vaccine-virus infection. Discuss timing of vaccination with your rheumatologist — in some cases, temporary discontinuation of methotrexate may be considered before vaccination, but only with medical supervision.
No. Adalimumab and other biologic immunosuppressants (including TNF inhibitors, IL inhibitors, and JAK inhibitors) are contraindications to live vaccines. M-M-R II should not be given while you are on any biologic therapy. Talk to your prescriber about vaccine timing — ideally, catch-up vaccinations should occur before starting biologic therapy.
General guidance is to wait at least 3 months after stopping most immunosuppressants before receiving live vaccines. However, the specific interval depends on which drug you were taking and at what dose. CAR-T therapy requires waiting until immune recovery. Always consult your provider and the current ACIP guidelines for specific intervals.
Yes. Blood products contain antibodies that can interfere with the immune response to M-M-R II, rendering the vaccine less effective. The required waiting period after a blood transfusion before receiving M-M-R II ranges from 3-11 months depending on the type of blood product received. Consult your provider and the ACIP table for specific intervals.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for M-M-R II also looked for:
More about M-M-R II
30,258 have already found their meds with Medfinder.
Start your search today.





